Wnt/β-catenin signaling in the development and therapeutic resistance of non-small cell lung cancer
Z Zhang, D Westover, Z Tang, Y Liu, J Sun… - Journal of Translational …, 2024 - Springer
Wnt/β-catenin signaling is a critical pathway that influences development and therapeutic
response of non-small cell lung cancer (NSCLC). In recent years, many Wnt regulators …
response of non-small cell lung cancer (NSCLC). In recent years, many Wnt regulators …
[HTML][HTML] Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer
T Li, W Ma, E Al-Obeidi - Cancers, 2024 - mdpi.com
First-line systemic therapy for patients with advanced or metastatic non-small cell lung
cancer (NSCLC) has rapidly evolved over the past two decades. First, molecularly targeted …
cancer (NSCLC) has rapidly evolved over the past two decades. First, molecularly targeted …
Exploring Inflammatory Parameters in Lung Cancer Patients: A Retrospective Analysis
CVI Feier, C Muntean, AM Faur, V Gaborean… - Journal of Personalized …, 2024 - mdpi.com
Inflammation-related parameters serve as pivotal indicators in the prognosis and
management of lung cancer. This retrospective investigation aimed to explore the …
management of lung cancer. This retrospective investigation aimed to explore the …
[HTML][HTML] Case Study 丨Professor Zhang Fang: Adequate dose, full course of treatment to protect the marrow, and the primary prevention of trilaciclib helps the first-line …
E Profile - laitimes.com
As an important means of anti-cancer treatment, chemotherapy is often accompanied by a
variety of side effects, among which chemotherapy-induced myelosuppression (CIM) is one …
variety of side effects, among which chemotherapy-induced myelosuppression (CIM) is one …